Galena Biopharma Reports Fourth Quarter And Year End 2013 Results
Published: Mar 18, 2014
PORTLAND, Ore., March 17, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today reported its financial results for the quarter and year ended December 31, 2013 and provided a business update.
Help employers find you! Check out all the jobs and post your resume.